MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 94 filers reported holding MERUS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.9%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $32,048,000 | 13.34% |
| Lynx1 Capital Management LP | 613,071 | $12,280,000 | 11.08% |
| Aquilo Capital Management, LLC | 1,507,109 | $30,187,000 | 10.88% |
| COMMODORE CAPITAL LP | 2,615,762 | $52,394,000 | 8.42% |
| MPM BioImpact LLC | 918,310 | $18,394,000 | 4.36% |
| BVF INC/IL | 3,444,420 | $68,992,000 | 2.85% |
| Boxer Capital, LLC | 1,900,000 | $38,057,000 | 2.14% |
| Opaleye Management Inc. | 253,200 | $5,072,000 | 2.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,136 | $5,912,000 | 2.00% |
| TCG Crossover Management, LLC | 300,000 | $6,009,000 | 1.80% |